Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years
• Australia will introduce revised cervical screening guidelines in 2017. • Cervical screening participation has fallen since introduction of the HPV vaccine. • The first study of Australian women examining their views of new screening methods. • Increased screening interval raised more concern than...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Jayasinghe, Yasmin [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management - Scheen, Marc ELSEVIER, 2022, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:76 ; year:2016 ; pages:74-80 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jcv.2015.10.026 |
|---|
| Katalog-ID: |
ELV019078021 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV019078021 | ||
| 003 | DE-627 | ||
| 005 | 20230623145727.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jcv.2015.10.026 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016003000023.pica |
| 035 | |a (DE-627)ELV019078021 | ||
| 035 | |a (ELSEVIER)S1386-6532(15)00734-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 616.019405 |q OCLC |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.45 |2 bkl | ||
| 100 | 1 | |a Jayasinghe, Yasmin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years |
| 264 | 1 | |c 2016 | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Australia will introduce revised cervical screening guidelines in 2017. • Cervical screening participation has fallen since introduction of the HPV vaccine. • The first study of Australian women examining their views of new screening methods. • Increased screening interval raised more concern than mode/delayed age of screening. | ||
| 650 | 7 | |a Young Female Health Initiative (YFHI) |2 Elsevier | |
| 650 | 7 | |a HPV testing |2 Elsevier | |
| 650 | 7 | |a Young women |2 Elsevier | |
| 650 | 7 | |a Cervical screening |2 Elsevier | |
| 650 | 7 | |a Theory of planned behavior |2 Elsevier | |
| 650 | 7 | |a Cervical cancer |2 Elsevier | |
| 650 | 7 | |a Renew |2 Elsevier | |
| 700 | 1 | |a Rangiah, Cheryl |4 oth | |
| 700 | 1 | |a Gorelik, Alexandra |4 oth | |
| 700 | 1 | |a Ogilvie, Gina |4 oth | |
| 700 | 1 | |a Wark, John D. |4 oth | |
| 700 | 1 | |a Hartley, Stefanie |4 oth | |
| 700 | 1 | |a Garland, Suzanne M. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Scheen, Marc ELSEVIER |t Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |d 2022 |g Amsterdam [u.a.] |w (DE-627)ELV007727844 |
| 773 | 1 | 8 | |g volume:76 |g year:2016 |g pages:74-80 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jcv.2015.10.026 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.45 |j Immunologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 76 |j 2016 |h 74-80 |g 7 |y 76.2016, S74-, (7 S.) | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
y j yj |
|---|---|
| matchkey_str |
jayasingheyasminrangiahcherylgorelikalex:2016----:rmrhvnbsdevclacrcenna2yasiwoyugut |
| hierarchy_sort_str |
2016 |
| bklnumber |
44.45 |
| publishDate |
2016 |
| allfields |
10.1016/j.jcv.2015.10.026 doi GBVA2016003000023.pica (DE-627)ELV019078021 (ELSEVIER)S1386-6532(15)00734-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Jayasinghe, Yasmin verfasserin aut Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Australia will introduce revised cervical screening guidelines in 2017. • Cervical screening participation has fallen since introduction of the HPV vaccine. • The first study of Australian women examining their views of new screening methods. • Increased screening interval raised more concern than mode/delayed age of screening. Young Female Health Initiative (YFHI) Elsevier HPV testing Elsevier Young women Elsevier Cervical screening Elsevier Theory of planned behavior Elsevier Cervical cancer Elsevier Renew Elsevier Rangiah, Cheryl oth Gorelik, Alexandra oth Ogilvie, Gina oth Wark, John D. oth Hartley, Stefanie oth Garland, Suzanne M. oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:76 year:2016 pages:74-80 extent:7 https://doi.org/10.1016/j.jcv.2015.10.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 76 2016 74-80 7 76.2016, S74-, (7 S.) 045F 610 |
| spelling |
10.1016/j.jcv.2015.10.026 doi GBVA2016003000023.pica (DE-627)ELV019078021 (ELSEVIER)S1386-6532(15)00734-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Jayasinghe, Yasmin verfasserin aut Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Australia will introduce revised cervical screening guidelines in 2017. • Cervical screening participation has fallen since introduction of the HPV vaccine. • The first study of Australian women examining their views of new screening methods. • Increased screening interval raised more concern than mode/delayed age of screening. Young Female Health Initiative (YFHI) Elsevier HPV testing Elsevier Young women Elsevier Cervical screening Elsevier Theory of planned behavior Elsevier Cervical cancer Elsevier Renew Elsevier Rangiah, Cheryl oth Gorelik, Alexandra oth Ogilvie, Gina oth Wark, John D. oth Hartley, Stefanie oth Garland, Suzanne M. oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:76 year:2016 pages:74-80 extent:7 https://doi.org/10.1016/j.jcv.2015.10.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 76 2016 74-80 7 76.2016, S74-, (7 S.) 045F 610 |
| allfields_unstemmed |
10.1016/j.jcv.2015.10.026 doi GBVA2016003000023.pica (DE-627)ELV019078021 (ELSEVIER)S1386-6532(15)00734-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Jayasinghe, Yasmin verfasserin aut Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Australia will introduce revised cervical screening guidelines in 2017. • Cervical screening participation has fallen since introduction of the HPV vaccine. • The first study of Australian women examining their views of new screening methods. • Increased screening interval raised more concern than mode/delayed age of screening. Young Female Health Initiative (YFHI) Elsevier HPV testing Elsevier Young women Elsevier Cervical screening Elsevier Theory of planned behavior Elsevier Cervical cancer Elsevier Renew Elsevier Rangiah, Cheryl oth Gorelik, Alexandra oth Ogilvie, Gina oth Wark, John D. oth Hartley, Stefanie oth Garland, Suzanne M. oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:76 year:2016 pages:74-80 extent:7 https://doi.org/10.1016/j.jcv.2015.10.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 76 2016 74-80 7 76.2016, S74-, (7 S.) 045F 610 |
| allfieldsGer |
10.1016/j.jcv.2015.10.026 doi GBVA2016003000023.pica (DE-627)ELV019078021 (ELSEVIER)S1386-6532(15)00734-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Jayasinghe, Yasmin verfasserin aut Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Australia will introduce revised cervical screening guidelines in 2017. • Cervical screening participation has fallen since introduction of the HPV vaccine. • The first study of Australian women examining their views of new screening methods. • Increased screening interval raised more concern than mode/delayed age of screening. Young Female Health Initiative (YFHI) Elsevier HPV testing Elsevier Young women Elsevier Cervical screening Elsevier Theory of planned behavior Elsevier Cervical cancer Elsevier Renew Elsevier Rangiah, Cheryl oth Gorelik, Alexandra oth Ogilvie, Gina oth Wark, John D. oth Hartley, Stefanie oth Garland, Suzanne M. oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:76 year:2016 pages:74-80 extent:7 https://doi.org/10.1016/j.jcv.2015.10.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 76 2016 74-80 7 76.2016, S74-, (7 S.) 045F 610 |
| allfieldsSound |
10.1016/j.jcv.2015.10.026 doi GBVA2016003000023.pica (DE-627)ELV019078021 (ELSEVIER)S1386-6532(15)00734-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Jayasinghe, Yasmin verfasserin aut Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Australia will introduce revised cervical screening guidelines in 2017. • Cervical screening participation has fallen since introduction of the HPV vaccine. • The first study of Australian women examining their views of new screening methods. • Increased screening interval raised more concern than mode/delayed age of screening. Young Female Health Initiative (YFHI) Elsevier HPV testing Elsevier Young women Elsevier Cervical screening Elsevier Theory of planned behavior Elsevier Cervical cancer Elsevier Renew Elsevier Rangiah, Cheryl oth Gorelik, Alexandra oth Ogilvie, Gina oth Wark, John D. oth Hartley, Stefanie oth Garland, Suzanne M. oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:76 year:2016 pages:74-80 extent:7 https://doi.org/10.1016/j.jcv.2015.10.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 76 2016 74-80 7 76.2016, S74-, (7 S.) 045F 610 |
| language |
English |
| source |
Enthalten in Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management Amsterdam [u.a.] volume:76 year:2016 pages:74-80 extent:7 |
| sourceStr |
Enthalten in Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management Amsterdam [u.a.] volume:76 year:2016 pages:74-80 extent:7 |
| format_phy_str_mv |
Article |
| bklname |
Immunologie |
| institution |
findex.gbv.de |
| topic_facet |
Young Female Health Initiative (YFHI) HPV testing Young women Cervical screening Theory of planned behavior Cervical cancer Renew |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| authorswithroles_txt_mv |
Jayasinghe, Yasmin @@aut@@ Rangiah, Cheryl @@oth@@ Gorelik, Alexandra @@oth@@ Ogilvie, Gina @@oth@@ Wark, John D. @@oth@@ Hartley, Stefanie @@oth@@ Garland, Suzanne M. @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV007727844 |
| dewey-sort |
3610 |
| id |
ELV019078021 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019078021</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623145727.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jcv.2015.10.026</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016003000023.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019078021</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1386-6532(15)00734-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.019405</subfield><subfield code="q">OCLC</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jayasinghe, Yasmin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Australia will introduce revised cervical screening guidelines in 2017. • Cervical screening participation has fallen since introduction of the HPV vaccine. • The first study of Australian women examining their views of new screening methods. • Increased screening interval raised more concern than mode/delayed age of screening.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Young Female Health Initiative (YFHI)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HPV testing</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Young women</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cervical screening</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Theory of planned behavior</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cervical cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Renew</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rangiah, Cheryl</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gorelik, Alexandra</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ogilvie, Gina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wark, John D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hartley, Stefanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Garland, Suzanne M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Scheen, Marc ELSEVIER</subfield><subfield code="t">Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007727844</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:76</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:74-80</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jcv.2015.10.026</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">76</subfield><subfield code="j">2016</subfield><subfield code="h">74-80</subfield><subfield code="g">7</subfield><subfield code="y">76.2016, S74-, (7 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Jayasinghe, Yasmin |
| spellingShingle |
Jayasinghe, Yasmin ddc 610 ddc 616.019405 bkl 44.45 Elsevier Young Female Health Initiative (YFHI) Elsevier HPV testing Elsevier Young women Elsevier Cervical screening Elsevier Theory of planned behavior Elsevier Cervical cancer Elsevier Renew Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years |
| authorStr |
Jayasinghe, Yasmin |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007727844 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 616 - Diseases |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years Young Female Health Initiative (YFHI) Elsevier HPV testing Elsevier Young women Elsevier Cervical screening Elsevier Theory of planned behavior Elsevier Cervical cancer Elsevier Renew Elsevier |
| topic |
ddc 610 ddc 616.019405 bkl 44.45 Elsevier Young Female Health Initiative (YFHI) Elsevier HPV testing Elsevier Young women Elsevier Cervical screening Elsevier Theory of planned behavior Elsevier Cervical cancer Elsevier Renew |
| topic_unstemmed |
ddc 610 ddc 616.019405 bkl 44.45 Elsevier Young Female Health Initiative (YFHI) Elsevier HPV testing Elsevier Young women Elsevier Cervical screening Elsevier Theory of planned behavior Elsevier Cervical cancer Elsevier Renew |
| topic_browse |
ddc 610 ddc 616.019405 bkl 44.45 Elsevier Young Female Health Initiative (YFHI) Elsevier HPV testing Elsevier Young women Elsevier Cervical screening Elsevier Theory of planned behavior Elsevier Cervical cancer Elsevier Renew |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
c r cr a g ag g o go j d w jd jdw s h sh s m g sm smg |
| hierarchy_parent_title |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| hierarchy_parent_id |
ELV007727844 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV007727844 |
| title |
Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years |
| ctrlnum |
(DE-627)ELV019078021 (ELSEVIER)S1386-6532(15)00734-9 |
| title_full |
Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years |
| author_sort |
Jayasinghe, Yasmin |
| journal |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| journalStr |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
74 |
| author_browse |
Jayasinghe, Yasmin |
| container_volume |
76 |
| physical |
7 |
| class |
610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Jayasinghe, Yasmin |
| doi_str_mv |
10.1016/j.jcv.2015.10.026 |
| dewey-full |
610 616.019405 |
| title_sort |
primary hpv dna based cervical cancer screening at 25 years: views of young australian women aged 16–28 years |
| title_auth |
Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years |
| abstract |
• Australia will introduce revised cervical screening guidelines in 2017. • Cervical screening participation has fallen since introduction of the HPV vaccine. • The first study of Australian women examining their views of new screening methods. • Increased screening interval raised more concern than mode/delayed age of screening. |
| abstractGer |
• Australia will introduce revised cervical screening guidelines in 2017. • Cervical screening participation has fallen since introduction of the HPV vaccine. • The first study of Australian women examining their views of new screening methods. • Increased screening interval raised more concern than mode/delayed age of screening. |
| abstract_unstemmed |
• Australia will introduce revised cervical screening guidelines in 2017. • Cervical screening participation has fallen since introduction of the HPV vaccine. • The first study of Australian women examining their views of new screening methods. • Increased screening interval raised more concern than mode/delayed age of screening. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years |
| url |
https://doi.org/10.1016/j.jcv.2015.10.026 |
| remote_bool |
true |
| author2 |
Rangiah, Cheryl Gorelik, Alexandra Ogilvie, Gina Wark, John D. Hartley, Stefanie Garland, Suzanne M. |
| author2Str |
Rangiah, Cheryl Gorelik, Alexandra Ogilvie, Gina Wark, John D. Hartley, Stefanie Garland, Suzanne M. |
| ppnlink |
ELV007727844 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| doi_str |
10.1016/j.jcv.2015.10.026 |
| up_date |
2024-07-06T20:30:03.213Z |
| _version_ |
1803862989302923264 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019078021</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623145727.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jcv.2015.10.026</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016003000023.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019078021</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1386-6532(15)00734-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.019405</subfield><subfield code="q">OCLC</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jayasinghe, Yasmin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Australia will introduce revised cervical screening guidelines in 2017. • Cervical screening participation has fallen since introduction of the HPV vaccine. • The first study of Australian women examining their views of new screening methods. • Increased screening interval raised more concern than mode/delayed age of screening.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Young Female Health Initiative (YFHI)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HPV testing</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Young women</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cervical screening</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Theory of planned behavior</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cervical cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Renew</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rangiah, Cheryl</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gorelik, Alexandra</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ogilvie, Gina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wark, John D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hartley, Stefanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Garland, Suzanne M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Scheen, Marc ELSEVIER</subfield><subfield code="t">Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007727844</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:76</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:74-80</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jcv.2015.10.026</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">76</subfield><subfield code="j">2016</subfield><subfield code="h">74-80</subfield><subfield code="g">7</subfield><subfield code="y">76.2016, S74-, (7 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4006004 |